Cargando…

The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients

INTRODUCTION: Previous studies have shown that inflammation may contribute to the interplay of endogenous glycosaminoglycans (GAGs) and anti-PF4 antibodies. In this study, we quantified the levels of anti-PF4 antibody isotypes and endogenous GAGs together with inflammatory biomarkers in pulmonary em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantarcioglu, Bulent, Darki, Amir, Siddiqui, Fakiha, Hoppensteadt, Debra, Lewis, Joseph, Krämer, Roland, Adiguzel, Cafer, Fareed, Jawed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980416/ https://www.ncbi.nlm.nih.gov/pubmed/35360982 http://dx.doi.org/10.1177/10760296221091770

Ejemplares similares

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
por: Allen, Madeline, et al.
Publicado: (2023)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2022)

Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2023)

Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
por: Mehrotra, Siddharth, et al.
Publicado: (2022)

Fibrinolytic Status and Risk of Death After Acute Pulmonary Embolism
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism
por: Darwish, Iman, et al.
Publicado: (2022)

The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients
por: Jaradeh, Mark, et al.
Publicado: (2021)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey
por: Kantarcioglu, Bulent, et al.
Publicado: (2021)

Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling
por: Bontekoe, Emily, et al.
Publicado: (2021)

Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism
por: Slajus, Brett, et al.
Publicado: (2021)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
por: Phan, Trung, et al.
Publicado: (2020)

Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic
por: Doan, Thao, et al.
Publicado: (2022)

Biomarkers of Thrombo-Inflammatory Responses in Pulmonary Embolism Patients With Pre-Existing Versus New-Onset Atrial Fibrillation
por: Patel, Dimpi, et al.
Publicado: (2021)

Arterial-renal Syndrome in Patients with ESRD, a New Disease Paradigm
por: Goldstein, Jake, et al.
Publicado: (2022)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events
por: Hussain, Mushtaq, et al.
Publicado: (2022)

Regulation of Cortisol in Patients Undergoing Total Joint Arthoplasty
por: Khanna, Rajan, et al.
Publicado: (2021)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation
por: Walborn, Amanda, et al.
Publicado: (2018)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
por: Fareed, Jawed, et al.
Publicado: (2011)

Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19
por: Marginean, Alexandru, et al.
Publicado: (2020)

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
por: Guler, Nil, et al.
Publicado: (2020)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2021)

Inflammatory Biomarker Profiling in Total Joint Arthroplasty and Its Relevance to Circulating Levels of Lubricin, a Novel Proteoglycan
por: Galicia, Kevin, et al.
Publicado: (2018)

Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers
por: Poredoš, Pavel, et al.
Publicado: (2023)

Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
por: Walborn, Amanda, et al.
Publicado: (2020)

National Trends for Peripheral Artery Disease and End Stage Renal Disease From the National Inpatient Sample Database
por: De Stefano, Frank, et al.
Publicado: (2021)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
por: Jeske, Walter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j6fljlcakhe3nh3scq5mt311g7